Texas SB2625 amends abortion-inducing drug provision rules, requiring physicians to be present in the state and personally examine the patient.
Texas SB2625 modifies the Health and Safety Code to restrict the provision of abortion-inducing drugs. It mandates that only physicians physically present in Texas and personally examining the pregnant woman can provide such drugs. Additionally, the bill requires physicians to schedule an in-person follow-up visit within 14 days to confirm the termination of the pregnancy and assess for continued blood loss. The changes take effect September 1, 2025.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.